Evidence map›Paper›PMID 37095280›Full record

ArticleCancer causes & control : CCC2023

Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer.

Madison M Wahlen, Ingrid M Lizarraga, Amanda R Kahl, Whitney E Zahnd, Jan M Eberth, Linda Overholser, Natoshia Askelson, Rachel Hirschey, Katherine Yeager, Sarah Nash and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Geographic distance to Commission on Cancer-accredited and nonaccredited hospitals in the United States.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Madison M WahlenDepartment of Epidemiology, University of Iowa, Iowa City, IA, USA.
Ingrid M LizarragaDepartment of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. Ingrid-lizarraga@uiowa.edu.
Amanda R KahlIowa Cancer Registry, Iowa City, IA, USA.
Whitney E ZahndDepartment of Health Management and Policy, University of Iowa, Iowa City, IA, USA.
Jan M EberthDepartment of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC, USA.
Linda OverholserDepartment of Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Natoshia AskelsonDepartment of Community and Behavioral Health, University of Iowa, Iowa City, IA, USA.
Rachel HirscheySchool of Nursing, University of North Carolina, Chapel Hill, NC, USA.
Katherine YeagerNell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA.
Sarah NashDepartment of Epidemiology, University of Iowa, Iowa City, IA, USA.
Jacklyn M EngelbartDepartment of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Mary E CharltonDepartment of Epidemiology, University of Iowa, Iowa City, IA, USA.
University of Iowa · USUniversity of Iowa Hospitals and Clinics · USDrexel University · USEmory University · USUniversity of Colorado Denver · USUniversity of North Carolina at Chapel Hill · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Health Promotion and Disease Prevention Research CenterU48DP006377 · DP · EMORY UNIVERSITY · PI KEGLER, MICHELLE C · 2018 to 2023
$13.5M
Project 3: MRI Imaging of Redox Active Fe Predicts GBM Responses to Pharmacological AscorbateP01CA217797 · NCI · UNIVERSITY OF IOWA · PI BUETTNER, GARRY R · 2018 to 2022
$9.6M
Understanding Pathways to Earlier Diagnosis for Ovarian Cancer in North CarolinaU48DP006400 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S, LEEMAN, JENNIFER · 2018 to 2023
$9.3M
University of Iowa Prevention Research Center for Rural HealthU48DP006389 · DP · UNIVERSITY OF IOWA · PI AFIFI, RIMA · 2018 to 2023
$7.4M
University of Iowa Surgical Oncology Training GrantT32CA148062 · NCI · UNIVERSITY OF IOWA · PI WEIGEL, RONALD J · 2010 to 2020
$3.8M
Physical activity intervention co-created and pilot tested with African American Colorectal Cancer SurvivorsK23MD015719 · NIMHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HIRSCHEY, RACHEL · 2021 to 2025
$795k
ACL HHS U48DP006399ACL HHS U48DP006401NCCDPHP CDC HHS U48 DP006377NCCDPHP CDC HHS U48 DP006389NCCDPHP CDC HHS U48 DP006400NCI NIH HHS HHSN261201800012INCI NIH HHS HHSN261201800012I/HHSN26100001NCI NIH HHS P01 CA217797NCI NIH HHS P30 CA086862NCI NIH HHS T32 CA148062NIH HHS NIH T32 CA148062NIMHD NIH HHS K23 MD015719NIMHD NIH HHS NIMHD K23 MD015719-01
6 · The paper itself

Abstract

purposeDespite lack of survival benefit, demand for contralateral prophylactic mastectomy (CPM) to treat unilateral breast cancer remains high. High uptake of CPM has been demonstrated in Midwestern rural women. Greater travel distance for surgical treatment is associated with CPM. Our objective was to examine the relationship between rurality and travel distance to surgery with CPM.

methodsWomen diagnosed with stages I-III unilateral breast cancer between 2007 and 2017 were identified using the National Cancer Database. Logistic regression was used to model likelihood of CPM based on rurality, proximity to metropolitan centers, and travel distance. A multinomial logistic regression model compared factors associated with CPM with reconstruction versus other surgical options.

resultsBoth rurality (OR 1.10, 95% CI 1.06-1.15 for non-metro/rural vs. metro) and travel distance (OR 1.37, 95% CI 1.33-1.41 for those who traveled 50 + miles vs. < 30 miles) were independently associated with CPM. For women who traveled 30 + miles, odds of receiving CPM were highest for non-metro/rural women (OR 1.33 for 30-49 miles, OR 1.57 for 50 + miles; reference: metro women traveling < 30 miles). Non-metro/rural women who received reconstruction were more likely to undergo CPM regardless of travel distance (ORs 1.11-1.21). Both metro and metro-adjacent women who received reconstruction were more likely to undergo CPM only if they traveled 30 + miles (ORs 1.24-1.30).

conclusionThe impact of travel distance on likelihood of CPM varies by patient rurality and receipt of reconstruction. Further research is needed to understand how patient residence, travel burden, and geographic access to comprehensive cancer care services, including reconstruction, influence patient decisions regarding surgery.

Indexed as

Breast NeoplasmsProphylactic MastectomyUnilateral Breast NeoplasmsFemaleHumansMastectomyProbabilityContralateral prophylactic mastectomyRuralityTravel distance

Identifiers

PMID37095280
PMCPMC10689552
OpenAlexW4366990123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.